LMP2 Inhibitors as a Potential Treatment for Alzheimer’s Disease-Reference-Cited by-同舟云学术

LMP2 Inhibitors as a Potential Treatment for Alzheimer’s Disease

Published:2020-03-19 Issue:7 Volume:63 Page:3763-3783
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Bhattarai Deepak¹,Lee Min Jae¹,Baek Ahruem²,Yeo In Jun³,Miller Zachary¹,Baek Yu Mi²,Lee Sukyeong⁴,Kim Dong-Eun²^ORCID,Hong Jin Tae³,Kim Kyung Bo¹^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, University of Kentucky, 789 South Limestone, Lexington, Kentucky 40536-0596, United States

2. Department of Bioscience and Biotechnology, Konkuk University, Seoul 05029, Republic of Korea

3. College of Pharmacy, Chungbuk National University, Cheongju, Chungbuk 28160, Republic of Korea

4. Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030, United States

Funder

National Cancer Institute

National Research Foundation of Korea

National Institute of General Medical Sciences

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c00416

Reference43 articles.

1. The immunoproteasome in antigen processing and other immunological functions

2. A patent review of immunoproteasome inhibitors

3. Brief treatment with a highly selective immunoproteasome inhibitor promotes long-term cardiac allograft acceptance in mice

4. The immunoproteasome‐specific inhibitor ONX 0914 reverses susceptibility to acute viral myocarditis

5. A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Microglial Immunoproteasome: A Novel Approach in Neuroinflammatory-Related Disorders;ACS Chemical Neuroscience;2024-07-06

2. Brain-Permeable Immunoproteasome-Targeting Macrocyclic Peptide Epoxyketones for Alzheimer’s Disease;Journal of Medicinal Chemistry;2024-04-18

3. Inhibition of Immunoproteasome Attenuates NLRP3 Inflammasome Response by Regulating E3 Ubiquitin Ligase TRIM31;Cells;2024-04-13

4. Ubiquitin E3 ligases assisted technologies in protein degradation: Sharing pathways in neurodegenerative disorders and cancer;Ageing Research Reviews;2024-04

5. Identification of differentially expressed exosome proteins in serum as potential biomarkers for cognitive impairments in cerebral small vessel disease;Neuroscience Letters;2024-02